BDRX

BDRX

USD

Biodexa Pharmaceuticals plc American Depositary Shs

$5.400+0.290 (5.675%)

Real-time Price

Healthcare
Biotechnology
United Kingdom

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$5.110

High

$5.860

Low

$5.110

Volume

0.03M

Company Fundamentals

Market Cap

3.3M

Industry

Biotechnology

Country

United Kingdom

Trading Stats

Avg Volume

0.18M

Exchange

NCM

Currency

USD

52-Week Range

Low $5Current $5.400High $92

Related News

GlobeNewswire

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion Biodexa

View more
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion